Revolutionizing Prostate Cancer Detection: The Role of Approved PSMA-PET Imaging Agents
Locametz<sup>®</sup>/Illuccix<sup>®</sup>/Gozellix<sup>TM</sup> (Novartis AG (Basel, Switzerland) and Telix Pharmaceuticals, Ltd. (Melbourne, Australia), all three [<sup>68</sup>Ga]Ga-PSMA-11), Pylarify<sup>®</sup>/Pylclari<sup>®</...
| Published in: | Pharmaceuticals |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-06-01
|
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/18/6/906 |